Cargando…
Ignoring SARS-CoV-2 testing performance during COVID-19
Autores principales: | Buchta, Christoph, Zeichhardt, Heinz, Griesmacher, Andrea, Schellenberg, Ingo, Kammel, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897733/ https://www.ncbi.nlm.nih.gov/pubmed/36746168 http://dx.doi.org/10.1016/S2666-5247(23)00030-7 |
Ejemplares similares
-
The importance of external quality assessment data in evaluating SARS-CoV-2 virus genome detection assays
por: Buchta, Christoph, et al.
Publicado: (2022) -
Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities
por: Buchta, Christoph, et al.
Publicado: (2023) -
Design of external quality assessment schemes and definition of the roles of their providers in future epidemics
por: Buchta, Christoph, et al.
Publicado: (2023) -
Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values
por: Lanser, Lukas, et al.
Publicado: (2020) -
Correlation of SARS-CoV-2 RNA and nucleocapsid concentrations in samples used in INSTAND external quality assessment schemes
por: Valiente, Esmeralda, et al.
Publicado: (2023)